Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines
Ji Eun Kim(Cancer Society of New Zealand), Bruce C. Baguley(Maurice Wilkins Centre)
Cited by 23
Related Papers
Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
|Oncology Letters|2019|61
Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
|BioMed Research International|2014|46
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
|PLoS ONE|2015|45
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors
|Frontiers in Genetics|2013|43